Skip to main content
logo
Liminatus Pharma, Inc. (LIMN)
NASDAQ: LIMN · Real-Time Price · USD
0.1400
-0.0099 (-6.60%)
At close: Aug 14, 2026, 4:00 PM EDT
0.132309
-0.0077 (-5.49%)
After-hours: Aug 14, 2026, 7:59 PM EDT

Liminatus Pharma Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
6178075349337
Market Cap Growth
-94.45%-79.39%6.12%-78.38%3.48%-
Enterprise Value
6179789--
Last Close Price
0.140.6111.2210.3310.129.78

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PB Ratio
--1.68-4.14-4.78-32.30-29.64

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
-10.88-0.15-1.03-1.02-1.53-1.16
Net Debt / Equity Ratio
3.51-0.11-1.03-0.99-1.06-1.16
Net Debt / EBITDA Ratio
--0.37---4.23-3.30
Net Debt / FCF Ratio
0.04-0.11-13.73-4.67-13.18-78.47
Quick Ratio
0.660.030.000.030.290.00
Current Ratio
0.960.050.210.120.390.19
Return on Assets (ROA)
--62.65%-54.41%-66.30%-35.51%-
Return on Capital Employed (ROCE)
3836.20%30.30%17.20%30.50%25.10%35.10%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-175.12%-61.82%-4.43%-6.60%-0.84%-1.66%
FCF Yield
-188.33%-60.43%-1.81%-4.43%-0.25%-0.05%
Buyback Yield / Dilution
-62.16%-35.73%82.93%-188.25%--
SEC Filings: 10-K · 10-Q